Gary Bridger Insider Trading
Get free email notifications about insider trading for Gary Bridger.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gary Bridger. Gary Bridger is a Director in AQUINOX PHARMACEUTICALS, INC ($AQXP) and a Director in ALDER BIOPHARMACEUTICALS INC ($ALDR) and a Director in X4 Pharmaceuticals, Inc ($ASNS).
Address: C/O FIVE CORNERS CAPITAL 700 W. GEORGIA STREET, SUITE 2500 VANCOUVER V7Y 1B3 A1
Companies in which Gary Bridger is an Insider
ALDER BIOPHARMACEUTICALS INC
Trading Symbol: ALDRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gary Bridger: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 03 2015
$ALDR Market Capitalization: $1.19B
$ALDR Previous Close: $23.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neoleukin Therapeutics, Inc.
Trading Symbol: NLTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gary Bridger: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 09 2018
$NLTX Market Capitalization: $451.60M
$NLTX Previous Close: $18.81
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
X4 Pharmaceuticals, Inc
Trading Symbol: ASNSIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Gary Bridger: Director
Holdings: 0 shares
Latest Transaction: Jun 02 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Gary Bridger
Sentiment: All, ALDR, NLTX, ASNS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | ASNS | X4 Pharmaceuticals ... | Bridger Gary | Director | Option Exercise | A | 9.50 | 6,000 | 57,000 | 6,000 | |
Jun 11 2020 | ASNS | X4 Pharmaceuticals ... | Bridger Gary | Director | Option Exercise | A | 8.69 | 3,427 | 29,781 | 3,427 | |
Mar 14 2019 | ASNS | X4 Pharmaceuticals ... | Bridger Gary | Director | Option Exercise | A | 10.44 | 21,570 | 225,191 | 21,570 | |
Mar 14 2019 | ASNS | X4 Pharmaceuticals ... | Bridger Gary | Director | Option Exercise | A | 10.44 | 21,570 | 225,191 | 21,570 | |
May 09 2018 | AQXP | AQUINOX PHARMACEUT ... | Bridger Gary | Director | Option Exercise | A | 13.10 | 15,000 | 196,500 | 15,000 | |
May 10 2017 | AQXP | AQUINOX PHARMACEUT ... | Bridger Gary | Director | Option Exercise | A | 13.74 | 9,000 | 123,660 | 9,000 | |
May 11 2016 | AQXP | AQUINOX PHARMACEUT ... | Bridger Gary | Director | Option Exercise | A | 7.73 | 7,500 | 57,975 | 7,500 |